Physician profile
Paul Shapiro
NPI 1699766634
$630.94
in general payments reported to CMS, 2019-2025
15 companies · $72.44 in 2025
The $72.44 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $446 · 2020: $97.43 · 2023: $15.22 · 2025: $72.44.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $87.66.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $87.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $85.32 | 2019-2025 | Va-Lcp |
| Allergan, INC. | $78.36 | 2019 | |
| Pacira Therapeutics, INC. | $74.38 | 2019 | |
| Scilex Pharmaceuticals INC. | $63.46 | 2019 | |
| Merz North America, INC. | $46.67 | 2020 | |
| Saol Therapeutics INC. | $46.56 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $43.11 | 2019 | |
| Amgen INC. | $39.83 | 2019 | |
| Tersera Therapeutics LLC | $35.48 | 2019 | |
| Medtronic USA, INC. | $34.95 | 2020 | |
| Bioventus LLC | $26.78 | 2019-2020 | |
| Fidia Pharma USA INC. | $16.03 | 2019 | |
| Abbvie INC. | $15.22 | 2023 | Botox |
| Ermi LLC | $13.35 | 2019 | |
| Lilly USA, LLC | $11.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Shapiro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.